Anti-IFFO1 monoclonal antibody

Pre-made anti-IFFO1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to IFFO1/IFFO1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2888-Ab-1/ GM-Tg-hg-IP2888-Ab-2Anti-Human IFFO1 monoclonal antibodyHuman
GM-Tg-rg-IP2888-Ab-1/ GM-Tg-rg-IP2888-Ab-2Anti-Rat IFFO1 monoclonal antibodyRat
GM-Tg-mg-IP2888-Ab-1/ GM-Tg-mg-IP2888-Ab-2Anti-Mouse IFFO1 monoclonal antibodyMouse
GM-Tg-cynog-IP2888-Ab-1/ GM-Tg-cynog-IP2888-Ab-2Anti-Cynomolgus/ Rhesus macaque IFFO1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2888-Ab-1/ GM-Tg-felg-IP2888-Ab-2Anti-Feline IFFO1 monoclonal antibodyFeline
GM-Tg-cang-IP2888-Ab-1/ GM-Tg-cang-IP2888-Ab-2Anti-Canine IFFO1 monoclonal antibodyCanine
GM-Tg-bovg-IP2888-Ab-1/ GM-Tg-bovg-IP2888-Ab-2Anti-Bovine IFFO1 monoclonal antibodyBovine
GM-Tg-equg-IP2888-Ab-1/ GM-Tg-equg-IP2888-Ab-2Anti-Equine IFFO1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2888-Ab-1/ GM-Tg-hg-IP2888-Ab-2; GM-Tg-rg-IP2888-Ab-1/ GM-Tg-rg-IP2888-Ab-2;
GM-Tg-mg-IP2888-Ab-1/ GM-Tg-mg-IP2888-Ab-2; GM-Tg-cynog-IP2888-Ab-1/ GM-Tg-cynog-IP2888-Ab-2;
GM-Tg-felg-IP2888-Ab-1/ GM-Tg-felg-IP2888-Ab-2; GM-Tg-cang-IP2888-Ab-1/ GM-Tg-cang-IP2888-Ab-2;
GM-Tg-bovg-IP2888-Ab-1/ GM-Tg-bovg-IP2888-Ab-2; GM-Tg-equg-IP2888-Ab-1/ GM-Tg-equg-IP2888-Ab-2
Products NameAnti-IFFO1 monoclonal antibody
Formatmab
Target NameIFFO1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-IFFO1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2888-Ag-1Recombinant multi-species IFFO1/ HOM-TES-103/ IFFO protein


    Target information

    Target IDGM-IP2888
    Target NameIFFO1
    Gene ID25900,320678,362437,712900,486725,101092618,506821,100146302
    Gene Symbol and Synonyms4733401N06Rik,A930037G23Rik,HOM-TES-103,IFFO,IFFO1,RGD1308257
    Uniprot AccessionQ0D2I5
    Uniprot Entry NameIFFO1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000010295
    Target ClassificationN/A

    The target: IFFO1, gene name: IFFO1, also named as HOM-TES-103, IFFO. This gene is a member of the intermediate filament family. Intermediate filaments are proteins which are primordial components of the cytoskeleton and nuclear envelope. The proteins encoded by the members of this gene family are evolutionarily and structurally related but have limited sequence homology, with the exception of the central rod domain. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.